secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunome Inc. (IMNM)
CIK:        0001472012
Form:       8-K
Filed at:   2021-08-05T23:59:59+00:00
Accession:  0001104659-21-100801
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunome CSO Michael Morin resigns to part-time Chief Scientist; salary cut to $60,000
--------------------------------------------------------------------------------

- Michael Morin resigned as CSO and EVP effective Aug 1, 2021; now part-time Chief Scientist (~5 days/month).
- Annual base salary reduced to $60,000; eligible for prorated 2021 bonus (target 40% of prior salary, 7 months).
- Equity vesting continues unchanged under existing grant agreements.
- Morin will report to Chief Development Officer and work primarily from home office.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472012/000110465921100801/0001104659-21-100801-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472012/000110465921100801/tm2124229d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-100801

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer